RNS Number : 7869H Valereum PLC 08 May 2025 This announcement contains information which, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 (as amended). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain. 08/05/25 Valereum Plc ("Valereum", "VLRM" or the "Company") Placing of £0.5 Million via Clear Capital Markets Valereum Plc (AQSE: VLRM) is pleased to announce a placing by Clear Capital Markets for a total of 12.5 million new ordinary shares of £0.001 each in the capital of the Company (the "Placing Shares") at an issue price of £0.04 per Placing Share (the "Placing Price"), raising gross proceeds of £500,000 (before expenses) (the "Placing"). The Placing Price represents a discount of approximately 22% to the average closing price of £0.5125 per share on the 4 days prior to entering into the agreement. The Placing is expected to complete by 14 May 2025 and is conditional only on the Placing Shares being admitted to trading on the AQSE Growth Market. This Placing will provide additional working capital for VLRM to support the launch and scaling of its digital asset services, particularly its RWA Markets business. The Board remains confident in the Company's ability to deliver shareholder value through its own distinctive path, one built on technology, regulatory readiness, and strategic independence. Warrant Issue In association with the capital raise, the Company has granted warrants to advisersto subscribe for 1,000,000 new ordinary shares at an exercise price of £0.04 per share for a period of 3 years. James Formolli, Chairman of Valereum Plc, commented: "Bringing in external investors represents a strong endorsement of the Company's vision and long-term potential. This new capital allows Valereum to move forward at pace, strengthens our balance sheet, and provides the resources needed for us to explore the exciting opportunities ahead." The Company looks forward to updating the market on further developments in due course. Admission: Application will be made for the new Placing Shares, which will rank pari passu with the existing Ordinary Shares in issue, to be admitted to trading on the AQSE Growth Market ("Admission"). Dealings are expected to commence on or around 14 May 2025 and the issue is subject only to Admission. Total voting rights: Following the issuance of the Placing Shares, the Company's total number of Ordinary Shares in issue will be 185,409,716. This figure may be used by shareholders as the denominator for the calculation to determine if they are required to notify the Company of their interest in, or a change to their interest in, the Company's securities pursuant to the Company's Articles. For more information, and the chance to have your questions directly answered by the management team, please head to our interactive investor hub via: Investor Hub. Here you will find all company news and additional content to explain Valereum Plc's strategy and products. For further information, please contact: Valereum Plc Peter Sekhon, Investor Relation Director Engage with the company directly Tel: +44 7938 767319 Investor Hub Stanford Capital Partners Bob Pountney/ Patrick Claridge Tel: +44 023 3650 3650 AQSE Corporate Adviser First Sentinel Corporate Finance Brian Stockbridge / Gabrielle Cordeiro Tel: +44 20 3855 5551 The Directors of the Company accept responsibility for the contents of this announcement. For more information, please visit the Company's website at www.vlrm.com or to engage with the Valereum Plc management team directly by asking questions, watching video summaries and seeing what other shareholders have to say. Navigate to our Interactive Investor hub here:Sign Up This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END NEXPKOBDBBKBBPK